Search Results - "Blesch, A."

Refine Results
  1. 1

    BDNF: The career of a multifaceted neurotrophin in spinal cord injury by Weishaupt, N., Blesch, A., Fouad, K.

    Published in Experimental neurology (01-12-2012)
    “…Brain-derived neurotrophic factor (BDNF) has been identified as a potent promoter of neurite growth, a finding that has led to an ongoing exploration of this…”
    Get full text
    Journal Article
  2. 2

    An improved method for generating human spinal cord neural stem cells by Li, Y., Kumamaru, H., Vokes, T.J., Tran, A.N., Shevinsky, C.A., Graham, L., Archuleta, K., Limon, K.R., Lu, P., Blesch, A., Tuszynski, M.H., Brock, J.H.

    Published in Experimental neurology (01-06-2024)
    “…Neural stem cells have exhibited efficacy in pre-clinical models of spinal cord injury (SCI) and are on a translational path to human testing. We recently…”
    Get full text
    Journal Article
  3. 3

    Local and remote growth factor effects after primate spinal cord injury by Brock, John H, Rosenzweig, Ephron S, Blesch, Armin, Moseanko, Rod, Havton, Leif A, Edgerton, V Reggie, Tuszynski, Mark H

    Published in The Journal of neuroscience (21-07-2010)
    “…Primate models of spinal cord injury differ from rodent models in several respects, including the relative size and functional neuroanatomy of spinal…”
    Get full text
    Journal Article
  4. 4

    Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury by Grill, R, Murai, K, Blesch, A, Gage, F. H, Tuszynski, M. H

    Published in The Journal of neuroscience (15-07-1997)
    “…The injured adult mammalian spinal cord shows little spontaneous recovery after injury. In the present study, the contribution of projections in the dorsal…”
    Get full text
    Journal Article
  5. 5

    A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury by Löw, K, Blesch, A, Herrmann, J, Tuszynski, M H

    Published in Gene therapy (01-05-2010)
    “…The identification of axon growth-promoting genes, and overexpression of these genes in central nervous system (CNS) neurons projecting to the spinal cord, has…”
    Get full text
    Journal Article
  6. 6

    Novel aspects of diagnostics and therapy of spinal cord diseases by Rupp, R, Blesch, A, Schad, L, Draganski, B, Weidner, N

    Published in Nervenarzt (01-08-2014)
    “…Both non-traumatic and traumatic spinal cord injuries have in common that a relatively minor structural lesion can cause profound sensorimotor and autonomous…”
    Get full text
    Journal Article
  7. 7

    Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1 by Weidner, N., Blesch, A., Grill, R.J., Tuszynski, M.H.

    Published in Journal of comparative neurology (1911) (01-11-1999)
    “…Schwann cells contribute to efficient axonal regeneration after peripheral nerve injury and, when grafted to the central nervous system (CNS), also support a…”
    Get full text
    Journal Article
  8. 8

    Robust Growth of Chronically Injured Spinal Cord Axons Induced by Grafts of Genetically Modified NGF-Secreting Cells by Grill, R.J., Blesch, A., Tuszynski, M.H.

    Published in Experimental neurology (01-12-1997)
    “…Little spontaneous regeneration of axons occurs after acute and chronic injury to the CNS. Previously we have shown that the continuous local delivery of…”
    Get full text
    Journal Article
  9. 9

    Leukemia Inhibitory Factor Augments Neurotrophin Expression and Corticospinal Axon Growth after Adult CNS Injury by Blesch, A, Uy, H. S, Grill, R. J, Cheng, J.-G, Patterson, P. H, Tuszynski, M. H

    Published in The Journal of neuroscience (01-05-1999)
    “…The cytokine leukemia inhibitory factor (LIF) modulates glial and neuronal function in development and after peripheral nerve injury, but little is known…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression by BLESCH, A, CONNER, J. M, TUSZYNSKI, M. H

    Published in Gene therapy (01-06-2001)
    “…Vector systems for the regulated and reversible expression of therapeutic genes are likely to improve the safety and efficacy of gene therapy for medical…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Nerve Replacement Strategies for Cavernous Nerves by May, F., Vroemen, M., Matiasek, K., Henke, J., Brill, T., Lehmer, A., Apprich, M., Erhardt, W., Schoeler, S., Paul, R., Blesch, A., Hartung, R., Gansbacher, B., Weidner, N.

    Published in European urology (01-09-2005)
    “…This article reviews novel restorative therapies for cavernous nerves that may be used to replace resected cavernous nerves at the time of pelvic surgery. A…”
    Get full text
    Journal Article
  14. 14

    Spinal cord injury: plasticity, regeneration and the challenge of translational drug development by Blesch, Armin, Tuszynski, Mark H

    Published in Trends in neurosciences (Regular ed.) (01-01-2009)
    “…Over the past three decades, multiple mechanisms limiting central nervous system regeneration have been identified. Here, we address plasticity arising from…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer by Blesch, Armin

    Published in Methods (San Diego, Calif.) (01-06-2004)
    “…Retroviral vectors have become an important tool for gene transfer in vitro and in vivo. Classical Moloney murine leukemia virus (MLV) based retroviral vectors…”
    Get full text
    Journal Article
  17. 17

    Induction of bone marrow stromal cells to neurons: Differentiation, transdifferentiation, or artifact? by Lu, Paul, Blesch, Armin, Tuszynski, Mark H.

    Published in Journal of neuroscience research (15-07-2004)
    “…Differentiation of stem cells toward a neuronal lineage normally involves a gradually progressive restriction in developmental potential and is regulated by a…”
    Get full text
    Journal Article
  18. 18

    Early-onset treadmill training reduces mechanical allodynia and modulates calcitonin gene-related peptide fiber density in lamina III/IV in a mouse model of spinal cord contusion injury by Nees, Timo A., Tappe-Theodor, Anke, Sliwinski, Christopher, Motsch, Melanie, Rupp, Rüdiger, Kuner, Rohini, Weidner, Norbert, Blesch, Armin

    Published in Pain (Amsterdam) (01-03-2016)
    “…Below-level central neuropathic pain (CNP) affects a large proportion of spinal cord injured individuals. To better define the dynamic changes of the spinal…”
    Get full text
    Journal Article
  19. 19

    Motor axonal regeneration after partial and complete spinal cord transection by Lu, Paul, Blesch, Armin, Graham, Lori, Wang, Yaozhi, Samara, Ramsey, Banos, Karla, Haringer, Verena, Havton, Leif, Weishaupt, Nina, Bennett, David, Fouad, Karim, Tuszynski, Mark H

    Published in The Journal of neuroscience (13-06-2012)
    “…We subjected rats to either partial midcervical or complete upper thoracic spinal cord transections and examined whether combinatorial treatments support motor…”
    Get full text
    Journal Article
  20. 20

    A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease by Tuszynski, Mark H, Thal, Leon, Pay, Mary, Salmon, David P, U, Hoi Sang, Bakay, Roy, Patel, Piyush, Blesch, Armin, Vahlsing, H Lee, Ho, Gilbert, Tong, Gang, Potkin, Steven G, Fallon, James, Hansen, Lawrence, Mufson, Elliott J, Kordower, Jeffrey H, Gall, Christine, Conner, James

    Published in Nature medicine (01-05-2005)
    “…Cholinergic neuron loss is a cardinal feature of Alzheimer disease. Nerve growth factor (NGF) stimulates cholinergic function, improves memory and prevents…”
    Get full text
    Journal Article